<PAGE>   1


                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   ----------

                                    FORM 10-Q

(Mark One)

[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

         For the quarterly period ended June 30, 2001

                                       OR

[ ]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

         For the transition period from ________________ to ___________________

                         Commission file number 1-11097

                       3CI COMPLETE COMPLIANCE CORPORATION
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

                    Delaware                                    76-0351992
                    --------                                    ----------
          (State or other jurisdiction of                    (I.R.S. Employer
           incorporation or organization)                    Identification No.)

                   910 Pierremont, #312 Shreveport, LA. 71106
                   ------------------------------------------
                    (Address of principal executive offices)
                                   (Zip Code)

                                  (318)869-0440
                                  -------------
              (Registrant's telephone number, including area code)

                                   ----------


         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

         YES [X]  NO [ ]

                                   ----------

         Indicate the number of shares outstanding of each of the issuer's
classes of Common Stock, as of the latest practicable date.

         The number of shares of Common Stock outstanding as of the close of
business on August 14, 2001, was 9,198,325.


<PAGE>   2




                       3CI COMPLETE COMPLIANCE CORPORATION


                                      INDEX


<Table>
<Caption>

                                                                                             PAGE
                                                                                            NUMBER
                                                                                            ------
<S>                                                                                         <C>
PART I.          FINANCIAL INFORMATION

      Item 1.    Financial Statements

                 Balance Sheets as of
                    June 30, 2001 (unaudited) and September 30, 2000 (audited)..............      3

                 Statements of Operations for the three and nine months ended
                    June 30, 2001 and 2000 (unaudited)......................................      4

                 Statements of Cash Flows for the
                     nine months ended June 30, 2001 and
                     2000 (unaudited).......................................................      5

                 Notes to Financial Statements (unaudited)..................................      6


      Item 2.    Management's Discussion and Analysis of Financial
                    Condition and Results of Operations.....................................      9

PART II.         OTHER INFORMATION

      Item 1.    Legal Proceedings  ........................................................     11

      Item 2.    Changes in Securities......................................................     11

      Item 3.    Defaults Upon Senior Securities............................................     11

      Item 4.    Submission of Matters to a Vote
                    Of Security Holders.....................................................     11

      Item 5.    Other Information  ........................................................     11

      Item 6.    Exhibits and Reports on Form 8-K...........................................     11

SIGNATURES..................................................................................     14
</Table>





                                       2


<PAGE>   3



ITEM 1.  FINANCIAL STATEMENTS

                       3CI COMPLETE COMPLIANCE CORPORATION
                                 BALANCE SHEETS


<Table>
<Caption>

                                                                                   June 30,         September 30,
                                                                                     2001               2000
                                                                                  (Unaudited)         (Audited)
                                                                                  ------------       ------------
<S>                                                                               <C>                <C>
                              ASSETS

Current Assets:
   Cash and cash equivalents                                                      $    556,084       $    561,189
   Accounts receivable, net allowances of $252,598 and $281,051
     at June 30, 2001 and September 30, 2000, respectively                           3,407,260          2,819,920
   Inventory                                                                            88,892             88,062
   Prepaid expenses                                                                    638,741            396,101
   Other current assets                                                                 15,523             65,420
                                                                                  ------------       ------------
       Total current assets                                                          4,706,500          3,930,692
                                                                                  ------------       ------------

Property, plant and equipment, at cost                                              14,530,803         14,381,550
      Accumulated depreciation                                                      (7,934,861)        (6,770,017)
                                                                                  ------------       ------------
         Net property, plant and equipment                                           6,595,942          7,611,533
                                                                                  ------------       ------------

Excess of cost over net assets acquired, net of accumulated amortization of
 $226,738 and $189,988 at June 30, 1999 and September 30, 2000, respectively           330,493            367,243

Other assets                                                                            25,630             15,929
                                                                                  ------------       ------------
       Total assets                                                               $ 11,658,565       $ 11,925,397
                                                                                  ============       ============


               LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
   Notes payable                                                                  $    453,338       $    227,898
   Current portion of long-term debt to unaffiliated lenders                           379,301            447,948
   Accounts payable                                                                    434,935            858,524
   Accounts payable to affiliated companies                                            201,153            486,502
   Accrued liabilities                                                                 745,950            693,869
   Dividends Payable                                                                 1,243,779            497,550
   Note payable to majority shareholder                                              5,229,379          5,629,379
                                                                                  ------------       ------------
        Total current liabilities                                                    8,687,835          8,841,670
                                                                                  ------------       ------------

Long-term debt to unaffiliated lenders, net of current portion                         423,672            702,760

                                                                                  ------------       ------------
        Total liabilities                                                            9,111,507          9,544,430
                                                                                  ------------       ------------


Shareholders' Equity:
   Preferred stock, $0 .01 par value, authorized 16,050,000 shares;
      issued and outstanding 7,750,000 at June 30, 2001 and
      September 30, 2000, respectively                                                  77,500             77,500
   Additional paid-in capital - preferred stock                                      7,672,500          7,672,500
   Common stock, $0.01 par value, authorized 40,450,000 shares;
     Issued and outstanding 9,232,825 at June 30, 2001 and
     September 30, 2000                                                                 92,329             92,329
   Less cost of treasury stock 34,500 shares and 34,500 shares at
     June 30, 2001 and September 30, 2000, respectively                                (51,595)           (51,595)
   Additional paid-in capital - common stock                                        20,471,145         20,400,778
   Accumulated deficit                                                             (25,714,821)       (25,810,545)
                                                                                  ------------       ------------
        Total shareholders' equity                                                   2,547,058          2,380,967
                                                                                  ------------       ============
        Total liabilities and shareholders' equity                                $ 11,658,565       $ 11,925,397
                                                                                  ============       ============
</Table>




 The accompanying notes are an integral part of these financial statements.




                                       3

<PAGE>   4
                       3CI COMPLETE COMPLIANCE CORPORATION
                            STATEMENTS OF OPERATIONS
                                   (UNAUDITED)



<Table>
<Caption>

                                                     For the three months ended June 30,   For the nine months ended June 30,
                                                            2001             2000              2001              2000
                                                        ------------      ------------      ------------      ------------

<S>                                                     <C>               <C>               <C>               <C>
Revenues                                                $  4,704,210      $  4,302,908      $ 14,379,117      $ 12,929,446
Expenses:
     Cost of services                                      3,131,487         3,087,853         9,447,035         8,861,923
     Depreciation and amortization                           397,903           428,303         1,200,601         1,272,753
     Selling, general and administrative expenses            747,938           725,766         2,107,053         1,928,819
                                                        ------------      ------------      ------------      ------------
     Income from operations                                  426,882            60,986         1,624,428           865,951

Other income (expense):
     Interest expense                                       (196,904)         (248,204)         (686,235)         (693,277)
     Other income (expense)                                   (3,132)          (41,123)          (96,281)         (136,709)
                                                        ------------      ------------      ------------      ------------
Income (loss) before income taxes                            226,846          (228,341)          841,912            35,965

Income taxes                                                      --                --                --                --
                                                        ------------      ------------      ------------      ------------

Net income (loss)                                       $    226,846      $   (228,341)     $    841,912      $     35,965
                                                        ============      ============      ============      ============


   Dividends on preferred stock                             (746,229)         (497,550)         (746,229)         (497,550)
                                                        ------------      ------------      ------------      ------------

Net income (loss) applicable to common shareholders     $   (519,383)     $   (725,891)     $     95,683      $   (461,585)
                                                        ============      ============      ============      ============

  Basic earnings (loss)  per common share               $      (0.06)     $      (0.08)     $       0.01      $      (0.05)
                                                        ============      ============      ============      ============


  Fully diluted earnings (loss) per share               $      (0.06)     $      (0.08)     $       0.01      $      (0.05)
                                                        ============      ============      ============      ============
</Table>



 The accompanying notes are an integral part of these financial statements.




                                       4
<PAGE>   5


                       3CI COMPLETE COMPLIANCE CORPORATION
                            STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)



<Table>
<Caption>

                                                                             For the nine months ended June 30,
                                                                                  2001              2000
                                                                                -----------      -----------
<S>                                                                             <C>              <C>
Cash flow from operating activities:
   Net income                                                                   $   841,912      $    35,965
   Adjustments to reconcile net income to net cash
      provided by operating activities:
      (Gain) loss on disposal of assets                                             (67,816)          10,626
      Non-cash interest expense                                                      70,367               --
      Depreciation and amortization                                               1,200,601        1,272,753
      Changes in operating assets and liabilities
            Increase in accounts receivable, net                                   (587,340)        (275,802)
            Increase in inventory                                                      (830)         (23,057)
            Increase in prepaid expenses                                           (242,640)        (282,628)
            Decrease in other current assets and other assets                        40,196          112,658
            Decrease in accounts payable                                           (423,589)         (82,621)
            Increase (decrease) in accounts payable to affiliated companies        (285,349)           2,551
            Decrease in accrued liabilities                                          52,081           60,238

                                                                                -----------      -----------
                          Total adjustments to net income                          (244,319)         794,718
                                                                                -----------      -----------
                          Net cash provided by operating activities                 597,593          830,683
                                                                                -----------      -----------

Cash flow from investing activities:
      Proceeds from sale of intangible assets                                        67,816               --
      Proceeds from sale of property, plant and equipment                                --           25,557
      Purchase of property, plant and equipment                                    (148,218)        (311,254)
                                                                                -----------      -----------
                          Net cash used in investing activities                     (80,402)        (285,697)
                                                                                -----------      -----------

Cash flow from financing activities:
      Proceeds from issuance notes payable                                          779,291          624,815
      Principal reduction of notes payable                                         (553,852)        (330,920)
      Proceeds from issuance of long-term debt to unaffiliated lenders                   --           22,867
      Reduction of long-term debt to unaffiliated lenders                          (347,735)        (604,844)
      Payment of note payable to majority shareholders                             (400,000)        (144,787)
                                                                                -----------      -----------
                          Net cash used in financing activities                    (522,296)        (432,869)
                                                                                -----------      -----------

Net increase (decrease) in cash and cash equivalents                                 (5,105)         112,117
                                                                                -----------      -----------

Cash and cash equivalents, beginning of period                                      561,189          236,387
                                                                                -----------      -----------

Cash and cash equivalents, end of period                                        $   556,084      $   348,504
                                                                                ===========      ===========
</Table>



The accompanying notes are an integral part of these financial statements.


                                       5

<PAGE>   6

                       3CI COMPLETE COMPLIANCE CORPORATION
                          NOTES TO FINANCIAL STATEMENTS
                                  JUNE 30, 2001
                                   (UNAUDITED)

(1) ORGANIZATION AND BASIS OF PRESENTATION

                  3CI Complete Compliance Corporation (the Company or 3CI), a
Delaware Corporation, is engaged in the collection, transportation, treatment
and disposal of biomedical waste in the southern and southeastern United States.

         Effective October 1, 1998, after approval by the then properly
constituted 3CI Board of Directors, Stericycle Inc., a Delaware corporation
("Stericycle") acquired 100% of the common stock of Waste Systems, Inc. ("WSI")
for $10 million. As a result of the transaction, WSI became a wholly owned
subsidiary of Stericycle. WSI owns 55.5% or 5,104,448 shares of the outstanding
common stock and 100% of the outstanding preferred stock of the Company.

         The accompanying unaudited condensed financial statements have been
prepared in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-Q and Article 10 of
Regulation S-X. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments (consisting
of normal recurring accruals) considered necessary for a fair presentation have
been included. Operating results for the three-month and nine-month period ended
June 30, 2001 are not necessarily indicative of the results that may be expected
for the year ended September 30, 2001.

The balance sheet at September 30, 2000, has been derived from the audited
financial statements at that date but does not include all of the information
and footnotes required by generally accepted accounting principles for complete
financial statements.

For further information, refer to the consolidated financial statements and
footnotes thereto included in the Registrant Company's annual report on Form
10-K for the year ended September 30, 2000.

(2) NET INCOME (LOSS) PER COMMON SHARE

The following table sets forth the computation of net income (loss) per common
share:

<Table>
<Caption>

                                                                      FOR THE THREE AND NINE MONTHS ENDED JUNE 30,
                                                        ------------------------------------------------------------------
                                                            2001             2000              2001               2000
                                                        ------------      ------------      ------------      ------------
<S>                                                     <C>               <C>               <C>               <C>
Numerator:
 Net income (loss)                                      $    226,846      ($   228,341)     $    841,912      $     35,965
 Less preferred dividends                                   (746,229)         (497,550)         (746,229)         (497,550)
                                                        ------------      ------------      ------------      ------------
 Net income (loss) after preferred dividends                (519,383)         (725,891)           95,683          (461,585)
Denominator:
Denominator for basic earnings per share
 --weighted  average shares                                9,198,325         9,198,325         9,198,325         9,198,325
                                                        ------------      ------------      ------------      ------------
Effect of dilutive securities:
    Preferred shares and warrants                                 --                --         8,195,630                --
                                                        ------------      ------------      ------------      ------------
Denominator for diluted earnings per share-adjusted
-weighted average shares and assumed conversions           9,198,325         9,198,325        17,393,955         9,198,325
                                                        ------------      ------------      ------------      ------------
Basic earnings (loss) per share                         $      (0.06)     $      (0.08)     $       0.01      $      (0.05)
                                                        ------------      ------------      ------------      ------------
Diluted earnings loss per share                         $      (0.06)     $      (0.08)     $       0.01      $      (0.05)
                                                        ------------      ------------      ------------      ------------
</Table>


                                       6
<PAGE>   7

         Included in the nine month period ended June 30, 2001, are 547,300
warrants that were issued to WSI with an exercise price between $0.10 and $0.20.
These warrants were included in the computation of diluted earnings per share
for the period. Stock options were not included in the net income per share
computation because they were anti-dilutive, as the exercise prices ranging from
$0.594 to $1.50 were greater than the average price of the common stock.

(3)      BUSINESS CONDITIONS

The Company has historically financed its working capital needs, capital
expenditures, and acquisitions using internally generated funds as well as
borrowings from third parties and advances from its majority shareholder, WSI.
The Company's indebtedness currently consists of amounts owed to WSI which are
described below, insurance premiums that are financed over the course of each
fiscal year, debt incurred in connection with the leasing of the Chem-Clav unit,
and the indebtedness incurred in connection with the purchase of rolling stock.

         On October 1, 1998, WSI and the Company amended and restated a
revolving promissory note (the Note) in the principal amount of 5,487,308.
Amounts due under the Note totaled $5,229,379 and $5,629,379 at June 30, 2001
and September 30, 2000, respectively. The Note bears interest at the prime rate,
which is currently 6.75%, plus 1.5%. The Company was required to maintain a
minimum level of net worth and comply with certain performance related
covenants. Interest under the note is due and payable in quarterly installments
on the last business day of each calendar quarter.

         As of June 30, 2000 the Company notified WSI that it anticipated that
it would fail to meet its net income requirement under the Note for the quarter
ended June 30, 2000. Accordingly, WSI and the Company amended and restated the
original note as of August 1, 2000. The Amended and Restated Promissory Note
(the "Amended Note") which matured October 1, 2000 called for interest to be
paid quarterly at prime rate plus 3.5%, per annum not to exceed 13%. In
connection with the Amended Note, in September 2000 3CI issued WSI warrants for
the purchase of up to 351,836 shares of 3CI Common stock at an exercise price of
$.20 per share. These warrants expire September 20, 2002. At issuance, the
warrants had an estimated fair value of $70,367, which was charged to interest
expense. WSI waived all existing events of default under the existing
indebtedness. As of October 1, 2000 the Amended Note was again extended to
January 1, 2001. In connection with the Amended Note, in December 2000 3CI
issued WSI warrants for the purchase of up to 541,286 shares of 3CI Common stock
at an exercise price of $.10 per share. These warrants expire December 20, 2002.
At issuance, these warrants had an estimated value of $70,367 which was charged
to interest expense. The amended note was again renewed and extended to July 1,
2001, with an interest rate equal to the prime rate plus 2.5% not to exceed 13%.
No warrants were issued with this renewal contingent upon the Company meeting a
minimum level of earnings before interest, taxes, depreciation, and amortization
("EBITDA").

         In June, 2001 the Company again renewed and extended the note to
October 1, 2001. The terms of the Amended and Restated Promissory note called
for interest to be paid quarterly at the prime rate plus 1.5%, per annum, not to
exceed 13%. In connection with the renewal terms the Company paid $400,000
against principal on June 27, 2001. The Amended Note requires the Company to
achieve a minimum level of Earnings before Interest, Taxes, Depreciation and
Amortization ("EBITDA"). If the financial covenant is not met then the Company
is required to issue warrants. WSI intends to support the Company through the
year 2001.

         In June 1999, the Company established a master lease agreement in the
amount of $3,000,000 with LaSalle National Leasing Corporation. Of the total,
$2,000,000 is to be utilized for the leasing of transportation equipment of
which $203,882 and $333,695 had been utilized at June 30, 2001, and 2000,
respectively, and $1,000,000 for the financing of equipment, of which $430,518
and $540,808 had been utilized at June 30, 2001 and 2000 respectively. This
agreement is guaranteed by Stericycle, Inc. which owns 100% of WSI.



                                       7
<PAGE>   8

         In February 2001, 3CI transferred to Stericycle, through WSI,
approximately 70 accounts located in the Houston, Texas area in exchange for a
reduction in interest due under the Amended Promissory note of approximately
$67,816. The accounts represented approximately $200,000 in annual revenue
during 2000.


(4)      PREFERRED STOCK

         On June 1, 2000 the Board of Directors of American 3CI declared a
$0.0705 dividend on the series B preferred stock which totaled $493,500 and
represented the undeclared dividends accrued for the period from June 24, 1999
through April 30, 2000. The resolution called for the payment in cash from funds
of the Corporation legally available for the payment of dividends, as and when
the Board of Directors may direct by further resolution of the Board. In
addition to the dividends declared, undeclared dividends in arrears for the
series B preferred stock totaled $96,514.

         Also on June 1, 2000 the Board of Directors declared a dividend of
$0.0054 for the Series C preferred stock totaling $4,050 and representing
dividends accrued for the period from April 6, 2000 to April 30, 2000. The
resolution called for payment in cash from funds legally available for the
payment of dividends, as and when the Board of Directors may direct by further
resolution of the Board. In addition to the dividends declared, undeclared
dividends in arrears for the series C preferred stock totaled $10,341.

         On June 30, 2001 the Board of Directors of American 3CI declared a
$0.0963 dividend on the series B preferred stock which totaled $674,014 and
represented undeclared dividends accrued for the period from May 1, 2000 through
June 30, 2001. The resolution called for the payment in cash from funds of the
Corporation legally available for the payment of dividends, as and when the
Board of Directors may direct by further resolution of the Board.

         On June 30, 2001 the Board of Directors of American 3CI declared a
$0.0963 dividend on the series C preferred stock which totaled $72,215 and
represented undeclared dividends accrued for the period from May 1, 2000 through
June 30, 2001. The resolution called for the payment in cash from funds of the
Corporation legally available for the payment of dividends, as and when the
Board of Directors may direct by further resolution of the Board.


(5)      COMMITMENTS AND CONTINGENCIES

         The Company is subject to certain other litigation and claims arising
in the ordinary course of business. In the opinion of management of the Company,
the amounts ultimately payable, if any, as a result of such litigation and
claims will not have a materially adverse effect on the Company's financial
position or results of operations.

         The Company operates within the regulated medical waste disposal
industry which is subject to intense governmental regulation at the federal,
state and local levels. The Company believes it is currently in compliance in
all material respects with all applicable laws and regulations governing the
medical waste disposal business. However, continuing expenditures may be
required in order for the Company to remain in compliance with existing and
changing regulations. Furthermore, because the medical waste disposal industry
is predicated upon the existence of strict governmental regulation, any material
relaxation of regulatory requirements governing medical waste disposal or of
their enforcement could result in a reduced demand for the Company's services
and have a material adverse effect on the Company's revenues and financial
condition. The scope and duration of existing and future regulations



                                       8
<PAGE>   9

affecting the medical waste disposal industry cannot be anticipated and are
subject to changing political and economic pressures.



Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

         The Company is engaged in the business of medical waste management
services in the southern and southeastern United States. The Company's customers
include regional medical centers, major hospitals, clinics, medical and dental
offices, veterinarians, pharmaceutical companies, retirement homes, medical
testing laboratories and other medical waste generators. Services include
collection, transportation, bar code identification and destruction by
controlled, high temperature incineration and alternative treatment
technologies.

RESULTS OF OPERATIONS


The following summarizes (in thousands) the Company's operations:

<Table>
<Caption>

                                             THREE MONTHS ENDED                  NINE MONTHS ENDED
                                                   JUNE 30,                           JUNE 30,
                                            2001             2000              2001               2000
                                        ------------      ------------      ------------      ------------
<S>                                     <C>               <C>               <C>               <C>
Revenues                                $      4,704      $      4,303      $     14,379      $     12,929
Cost of services                              (3,131)           (3,087)           (9,447)           (8,862)
Depreciation and amortization                   (398)             (428)           (1,201)           (1,273)
Selling, general and administrative             (748)             (726)           (2,107)           (1,929)
                                        ------------      ------------      ------------      ------------
Net income from operations                       427                61             1,624               866
                                        ------------      ------------      ------------      ------------
Interest expense                                (197)             (248)             (686)             (693)
Other income (expense) net                        (3)              (41)              (96)             (137)
                                        ------------      ------------      ------------      ------------
Net income                              $        227      $       (228)     $        842      $         36
                                        ============      ============      ============      ============
EBITDA*                                 $        822      $        448      $      2,728      $      2,002
                                        ============      ============      ============      ============
</Table>

(1) EBITDA is calculated as the sum of net income, plus interest expense, income
tax expense, depreciation expense, and amortization expense. We consider EBITDA
to be a widely accepted financial indicator of a company's ability to service
debt, fund capital expenditures and expand its business. EBITDA is not
calculated in the same way by all companies, is not a measurement required by
generally accepted accounting principles and does not represent cash flow from
operations as defined by generally accepted accounting principles. EBITDA should
not be considered as an alternative to net income, as an indicator of operating
performance or as an alternative to cash flow as a measure of liquidity.

----------


THREE MONTHS ENDED JUNE 30, 2001 COMPARED TO THREE MONTHS ENDED JUNE 30, 2000:

REVENUES increased by $401,302, or approximately 9.33%, to $4,704,210 during the
three months period ended June 30, 2001, from $4,302,908 for the three-month
period ended June 30, 2000. This increase is primarily due to an increase in
pricing strategy necessary to cover higher operating costs. The new pricing was
implemented in December 2000.

COST OF SERVICES increased $43,633 or approximately 1.41%, to $3,131,487 during
the three months ended June 30, 2001, compared to $3,087,853 for the three month
period ended June 30, 2000. The increase



                                       9
<PAGE>   10

was primarily related to an increase in external processing fees that have been
incurred as the Company was refurbishing its own treatment facilities. Also the
Company has incurred increased transportation costs related to the rise in
diesel fuel and other petroleum based products that the Company utilizes in its
business. Cost of revenues as a percentage of revenues decreased to 66.6% during
the three months ended June 30, 2001, as compared to 71.8% during the three
months ended June 30, 2000.

DEPRECIATION AND AMORTIZATION expense decreased to $397,903 for the three months
ended June 30, 2001, from $428,303, for the three months ended June 30, 2000.
The decrease was related to certain assets becoming fully depreciated.

SELLING, GENERAL AND ADMINISTRATIVE expenses increased to $747,938, during the
three months ended June 30, 2001, from $725,766, during the three months ended
June 30, 2000. This increase of $22,172, or 3.1%, is primarily attributable to
legal fees and settlements related to certain employment issues net of an
overall reduction in various administrative expenses. Selling, general and
administrative expenses decreased as a percentage of revenue to 15.9% for the
three months ended June 30, 2001, as compared to 16.9% for the three months
ended June 30, 2000.

INTEREST EXPENSE decreased by $51,300, or 20.7%, to $196,904 during the three
months ended June 30, 2001, as compared to $248,204 for the three month period
ended June 30, 2000. The primary reason for the reduction in interest was the
reduction of the interest rates for the note payable to WSI, which is variable
and tied to the prime rate.

EARNINGS BEFORE INTEREST TAXES DEPRECIATION AND AMORTIZATION ("EBITDA") totaled
$821,653 or 17.47% of revenue for the quarter ended June 30, 2001 compared to
$448,166 or 10.42% of revenue for the quarter ended June 30, 2000. This increase
was primarily the result of the increased profitability created by the pricing
strategy as referred to above which was implemented in December 2000.

NINE MONTHS ENDED JUNE 30, 2001 COMPARED TO NINE MONTHS ENDED JUNE 30, 2000:

REVENUES increased by $1,449,671, or 11.2%, to $14,379,117 during the nine
months period ended June 30, 2001, from $12,929,446 for the nine month period
ended June 30, 2000. This increase is primarily due to an increase in pricing
strategy necessary to cover higher operating costs. The new pricing was
implemented in December 2000.

COST OF SERVICES increased $585,112, or 6.6%, to $9,447,035, during the nine
months ended June 30, 2001, compared to $8,861,923 for the nine month period
ended June 30, 2000. The increase in cost of services is also attributable to
the increase of the Company's packaging and container costs, transportation
costs and external processing fees. Cost of revenues as a percentage of revenues
decreased to 65.7% during the nine months ended June 30, 2000, as compared to
68.8% during the nine months ended June 30, 2000.

DEPRECIATION AND AMORTIZATION expense decreased to $1,200,601 for the nine
months ended June 30, 2001, from $1,272,753 for the nine months ended June 30,
2000. The decrease was related to certain assets becoming fully depreciated.

SELLING, GENERAL AND ADMINISTRATIVE expenses increased to $2,107,053 during the
nine months ended June 30, 2001, from $1,928,819 during the nine months ended
June 30, 2000. This increase of $178,234, or 9.2%, is primarily attributable to
the benefit of a $200,000 insurance settlement in the period ended June 20,
2000. Selling, general and administrative expenses decreased as a percentage of
revenue to 14.7% for the nine months ended June 30, 2001, as compared to 14.8%
for the nine months ended June 30, 2000.



                                       10
<PAGE>   11

INTEREST EXPENSE decreased by $7,042 or 1.0% to $686,235 during the nine months
ended June 30, 2001 as compared to $693,277 during the nine months ended June
30, 2000. This decrease was primarily due to a reduction in the interest rate
for the note payable to WSI, which is variable and tied to the prime interest
rate.

EARNINGS BEFORE INTEREST TAXES DEPRECIATION AND AMORTIZATION ("EBITDA") totaled
$2,728,748 or 19.0% of revenue for the nine months ended June 30, 2001 compared
to $2,001,995 or 15.4% of revenue for the nine months ended June 30, 2000. This
increase was primarily the result of the newly implemented pricing strategy as
referred to above.

                         LIQUIDITY AND CAPITAL RESOURCES


         At June 30, 2001, the Company had net working capital, exclusive of the
note payable to its majority shareholder, of $1,248,044 compared to a net
working capital exclusive of the note payable to its majority shareholder of
$718,401 at September 30, 2000. This increase in net working capital of $529,643
is related to increase in accounts receivable and prepaid assets.

         Net cash provided by operating activities was $597,593 during the
nine-month period ended June 30, 2001, compared to net cash provided by
operating activities of $830,683 for the nine-month period ended June 30, 2000.
This decrease of $233,090 was due to the increase in current assets, primarily
accounts receivable, and repayment of current liabilities.

         Net cash used in investing activities for the nine months ended June
30, 2001, was $80,402 compared to $285,697 for the similar period in 2000.
During the period the Company invested $148,218 for purchases of machinery and
equipment, and computer equipment and software.

         Net cash used in financing activities was $522,296 during the
nine-month period ended June 30, 2001, as compared to net cash used in financing
activities of $432,869 during the nine month period ended June 30, 2000. The
difference is primarily the result of the repayment of debt to WSI.

                           PART II - OTHER INFORMATION

Item 1.  Legal Proceedings -

         The Company is subject to certain other litigation and claims arising
in the ordinary course of business. Management believes the amounts ultimately
payable, if any, as a result of such claims and assessments will not have a
materially adverse effect on the Company's financial position, results of
operations or net cash flows.

Item 2.  Changes in Securities - None

Item 3.  Defaults Upon Senior Securities - None

Item 4.  Submission of Matters to a Vote of Security Holders - None

Item 5.  Other Information - None

Item 6.  Exhibits and Reports on Form 8-K -




                                       11
<PAGE>   12

<Table>
<Caption>

EXHIBIT
NUMBER                              DESCRIPTION
------                              -----------
<S>         <C>

3.1.        Certificate of Incorporation as amended (incorporated by reference
            to Exhibit 3(a) of 3CI's registration statement on Form S-1 (No.
            33-45632) effective April 14, 1992).

3.2.        Amendment to 3CI's Certificate of Incorporation, as amended
            effective June 13, 1995 (incorporated by reference to Exhibit 3.1 of
            3CI's Quarterly Report on Form 10-Q for the quarterly period ended
            June 30, 1995).

3.3.        Amendment to 3CI's Certificate of Incorporation, as amended
            effective March 23, 1998 (incorporated by reference to Exhibit 3.3
            of 3CI's registration statement on Form S-1 (No. 333-48499), filed
            March 24, 1998).

3.4         Bylaws, effective May 14, 1995 (incorporated by reference to Exhibit
            3.2 of 3CI's Quarterly Report on Form 10-Q for the quarterly period
            ended June 30, 1995).

3.5         Amendment of Bylaws effective October 1, 1998.(incorporated by
            reference to Exhibit 3.5 of 3CI's report on Form 10-K filed January
            12, 1999)

3.6.        Certificate of Designations of 3CI's Series A Preferred Stock
            without par value (incorporated by reference to Exhibit 3.6 of 3CI's
            registration statement on Form S-1 (No. 333-48499), filed March 24,
            1998).

3.7.        Certificate of Designations of 3CI's Series B Preferred Stock
            without par value (incorporated by reference to Exhibit 3.7 of 3CI's
            registration statement on Form S-1 (No. 333-48499), filed March 24,
            1998).

3.8.        Certificate of Designations of 3CI's Series C Preferred Stock
            without par value (incorporated by reference to Exhibit 3.8 of 3CI's
            registration statement on Form S-1 (No. 333-48499), filed March 24,
            1998).

4.1         Amended and Restated Secured Promissory Note dated October 1, 1998,
            in the principal amount of $5,487,307.13 between 3CI and Waste
            Systems, Inc. (incorporated by reference to Exhibit 4.4 of 3CI's
            report on Form 10-K filed January 12, 1999).

4.2         Loan Agreement and Note Amendment dated December 18, 1998, by 3CI
            and Waste Systems, Inc. (incorporated by reference to Exhibit 4.5 of
            3CI's report on Form 10-K filed January 12, 1999).

4.3         Letter Agreement and Note Amendment dated August 10, 2000 by 3CI and
            Waste Systems, Inc. (incorporated by reference to Exhibit 4.3 of
            3CI's report on Form 10-K filed December 29, 2000).

4.4         Letter Agreement and Note Amendment dated December 20, 2000 by 3CI
            and Waste Systems, Inc. (incorporated by reference to Exhibit 4.4 of
            3CI's report on Form 10-K filed December 29, 2000).

4.5         Letter Agreement and Note Amendment dated July 1, 2001 by 3CI and
            Waste Systems, Inc.

10.1        1992 Stock Option Plan of 3CI (incorporated by reference to Exhibit
            10(m) of 3CI's registration statement on Form S-1 (No. 33-45632)
            effective April 14, 1992).

10.2        Settlement Agreement dated January 1996 between James Shepherd,
            Michael Shepherd and Richard T. McElhannon as Releassors, and the
            Company, Georg Rethmann, Dr. Herrmann Niehues, Jurgen Thomas,
            Charles Crochet and Waste Systems, Inc., as Releasees (incorporated
            by reference to Exhibit 10.23 of 3CI's report on Form 10-K filed
            January 14, 1997).

10.3        Exchange Agreement between 3CI and Waste Systems, Inc. dated as of
            June 24, 1997 (incorporated by reference to Exhibit 10.12 of 3CI's
            registration statement on Form S-1 (No. 333-48499), filed March 24,
            1998).

10.4        Stock Purchase and Note Modification Agreement between 3CI and Waste
            Systems, Inc. dated as of February 19, 1998 (incorporated by
            reference to Exhibit 10.13 of 3CI's registration statement on Form
            S-1 (No. 333-48499), filed March 24, 1998).
</Table>



                                       12
<PAGE>   13
<Table>
<S>         <C>
10.5        Employment Agreement dated May 30, 1998, between 3CI and Charles D.
            Crochet (incorporated by reference to Exhibit 10.9 of 3CI's
            registration statement on Form S-1 (No. 333-48499), filed March 24,
            1998).

10.6        Agreement dated September 30, 1998 among 3CI, Waste Systems, Inc.
            and Stericycle, Inc. regarding Section 203 of the Delaware General
            Corporation Law (incorporated by reference to Exhibit 10.14 of 3CI's
            report on Form 10-K filed January 12, 1999).

10.7        Form of Indemnification Agreement dated August 26, 1998 entered into
            between 3CI and Valerie Banner, David Schoonmaker, Charles Crochet,
            Juergen Thomas, Dr. Werner Kook and Dr. Clemens Pues (incorporated
            by reference to Exhibit 10.15 of 3CI's report on Form 10-K filed
            January 12, 1999).

10.8        Form of Indemnification Agreement dated June 3, 1999 entered into
            between 3CI and Robert Waller (incorporated by reference to Exhibit
            10.11 of 3CI's report on Form 10-K filed January 12, 2000).

10.9        LaSalle National Leasing master lease agreement dated June 18, 1999
            between LaSalle National Leasing as lessor and the Company as lessee
            (incorporated by reference to Exhibit 10.12 of 3CI's report on Form
            10-K filed January 12, 2000).
</Table>


-------------------


REPORTS ON FORM 8-K - NONE



                                       13
<PAGE>   14





                                   SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                           3CI COMPLETE COMPLIANCE
                                           CORPORATION
                                           (Registrant)





Dated: August 14, 2001

                                           By: /s/ JOHN R. WEAVER
                                              ----------------------------------
                                                      John R. Weaver
                                                  Chief Financial Officer,
                                                (Principal Financial Officer,
                                                Principal Accounting Officer)













                                   SIGNATURES



                                       14
<PAGE>   15

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                           3CI COMPLETE COMPLIANCE
                                           CORPORATION
                                           (Registrant)





Dated: August 14, 2001

                                           By: /s/ JOHN R. WEAVER
                                               ---------------------------------
                                                          John R.  Weaver
                                                     Chief Financial Officer,
                                                  (Principal Financial Officer,
                                                  Principal Accounting Officer)





                                       15
<PAGE>   16




                                 EXHIBIT INDEX

<Table>
<Caption>

EXHIBIT
NUMBER      DESCRIPTION
------      -----------
<S>         <C>
4.5         Letter Agreement and Note Amendment dated July 1, 2001 by 3CI and
            Waste Systems, Inc.
</Table>